Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study (Q85448625)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 December 2012
edit
Language Label Description Also known as
English
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study
scientific article published on 01 December 2012

    Statements

    title
    Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    23154554
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23154554%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    18 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q85448625&oldid=2138135228"